Axonyx Inc (AXYX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Axonyx Inc (AXYX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: wontgetfooledagin who wrote (7)	4/23/2004 11:42:13 AM
From: VIXandMore	Read Replies (1) of 22

Feurstein mentions AXYX as possible acquisition candidate for FRX, pushing AXYX to 52WH thestreet.com Adam Feuerstein Forest Labs Falls on Celexa Worries; Is an Acquisition in the Cards? 4/23/04 10:36 AM ET Forest Labs (FRX:NYSE) getting unhinged this morning on the Prudential downgrade today, and more negative commentary yesterday from SG Cowen. The big concern: How soon will the antidepressant Celexa face generic competition? Some are saying generic could arrive as early as the second half of this year. Others are betting that FRX has a strategy to extend Celexa's patent life. For what it's worth, some of my sources who own FRX are buying the weakness. Another interesting angle here: This morning's Prudential note talks about the possibility of FRX buying someone to make up for lost Celexa revenue. Well, how about FRX buying Axonyx (AXYX:Nasdaq) to bolster its Alzheimer's drug franchise? FRX's Namenda would be complementary to AXYX's experimental Alzheimer's drug Phenserine, especially since data suggest Namenda works better in combo. There has already been chatter about FRX partnering with AXYX, but why not just buy the whole company? Just a thought.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next